Literature DB >> 1444314

Effects of diclofenac on ceftriaxone pharmacokinetics in humans.

M Merle-Melet1, L Bresler, F Lokiec, C Dopff, P Boissel, J B Dureux.   

Abstract

The effects of diclofenac, a nonsteroidal antiinflammatory drug, on the biliary and urinary excretion of ceftriaxone were evaluated in subjects with a T drain in the common bile duct. The kinetic study was carried out on the sixth postoperative day of treatment with ceftriaxone alone (2 g intravenously; group 1) or ceftriaxone combined with diclofenac (50 mg every 12 h orally from postoperative days 3 to 6; group 2). A significant increase in the elimination half-life of ceftriaxone was observed in group 2 patients. Diclofenac caused a significant rise in ceftriaxone biliary excretion. This increase was not sufficient to balance the significant deficit of urinary excretion of ceftriaxone.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1444314      PMCID: PMC245498          DOI: 10.1128/AAC.36.10.2331

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  13 in total

1.  Reduction in biliary excretion of ceftriaxone by diclofenac in rabbits.

Authors:  M Merle-Melet; N Seta; R Farinotti; C Carbon
Journal:  Antimicrob Agents Chemother       Date:  1989-09       Impact factor: 5.191

2.  Chronic progressive osteoblastic osteomyelitis: a new approach to treatment.

Authors:  C Törholm; S A Hedström; K Herrlin; O Johnell; L Lidgren
Journal:  J Pediatr Orthop       Date:  1988 May-Jun       Impact factor: 2.324

3.  Nonsteroidal anti-inflammatory agents in the therapy for experimental pneumococcal meningitis.

Authors:  E Tuomanen; B Hengstler; R Rich; M A Bray; O Zak; A Tomasz
Journal:  J Infect Dis       Date:  1987-05       Impact factor: 5.226

Review 4.  Influence of binding on the pharmacologic activity of antibiotics.

Authors:  C M Kunin; W A Craig; M Kornguth; R Monson
Journal:  Ann N Y Acad Sci       Date:  1973-11-26       Impact factor: 5.691

5.  Effect of some drugs on penicillin half-life in blood.

Authors:  J Kampmann; J M Hansen; K Siersboek-Nielsen; H Laursen
Journal:  Clin Pharmacol Ther       Date:  1972 Jul-Aug       Impact factor: 6.875

6.  Enhancement of the therapeutic effect of cephalosporins in experimental endocarditis by altering their pharmacokinetics with diclofenac.

Authors:  V Joly; B Pangon; N Brion; J M Vallois; C Carbon
Journal:  J Pharmacol Exp Ther       Date:  1988-08       Impact factor: 4.030

7.  Effects of phenylbutazone on extravascular diffusion, protein binding and urinary excretion of cefazolin in rabbits.

Authors:  C Carbon; A Contrepois; Y Nivoche; M Grandjean; S Decourt; N P Chau
Journal:  J Pharmacol Exp Ther       Date:  1981-08       Impact factor: 4.030

8.  Biliary excretion and pharmacokinetics of ceftriaxone after cholecystectomy.

Authors:  W L Hayton; R Schandlik; K Stoeckel
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

9.  Effect of ibuprofen on gross pathology, bacterial count, and levels of prostaglandin E2 in experimental staphylococcal osteomyelitis.

Authors:  J P Rissing; T B Buxton
Journal:  J Infect Dis       Date:  1986-10       Impact factor: 5.226

10.  Renal disposition of ceftazidime illustrated by interferences by probenecid, furosemide, and indomethacin in rabbits.

Authors:  C Carbon; F Dromer; N Brion; A C Cremieux; A Contrepois
Journal:  Antimicrob Agents Chemother       Date:  1984-09       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.